title: Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
abstract: The tropism of breast cancer cells for bone and their tendency to induce an osteolytic phenotype are a result of interactions between breast cancer cells and stromal cells and are of paramount importance for bone metastasis. However, the underlying molecular mechanisms remain poorly understood. We hypothesize that tumor-stromal interaction alters gene expression in malignant tumor cells and stromal cells creating a unique expression signature that promotes osteolytic breast cancer bone metastasis and that inhibition of such interactions can be developed as targeted therapeutics. Microarray analysis was performed to investigate gene expression profiling at the tumor-bone (TB) interface versus the tumor alone area from syngenic mice injected with three different syngenic mammary tumor cell lines that differ in their metastatic potential. We identified matrix metalloproteinase 13 (MMP13), receptor activator of NF-kappaB ligand (RANKL), and integrins binding sialoprotein to be genes upregulated at the TB interface and validated. To determine the functional role of MMP13 in tumor-induced osteolysis, mice with Cl66 mammary tumors were treated with MMP13 antisense oligonucleotides (MMP13-ASO) or control scrambled oligonucleotides (control-ASO). Knockdown of MMP13 expression at the TB interface leads to significant reduction in bone destruction and in the number of activated osteoclasts at the TB interface. Further analysis to evaluate the mechanism of MMP13-dependent osteolytic bone metastasis revealed that MMP13-ASO treatment decreased active MMP9, RANKL levels, and transforming growth factor-beta signaling at the TB interface. Together, our data indicate that upregulation of MMP13 at the TB interface is important in tumor-induced osteolysis and suggest that MMP13 is a potential therapeutic target for breast cancer bone metastasis.
authors.affiliation: Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5900, USA.
authors.forename: Kalyan C
authors.initials: KC
authors.lastname: Nannuru
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Futakuchi
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Varney
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Vincent
authors.forename: Eric G
authors.initials: EG
authors.lastname: Marcusson
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Singh
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology / Q000473:pathology; D000818:Animals; D001859:Bone Neoplasms / Q000201:enzymology / Q000378:metabolism / Q000556:secondary*; D001842:Bone and Bones / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D004789:Enzyme Activation; D005260:Female; D020869:Gene Expression Profiling; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology*; D053509:Matrix Metalloproteinase 13 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D061965:Matrix Metalloproteinase Inhibitors; D051379:Mice; D008807:Mice, Inbred BALB C; D010010:Osteoclasts / Q000201:enzymology / Q000473:pathology; D010014:Osteolysis / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D053244:Osteoprotegerin / Q000096:biosynthesis; D053245:RANK Ligand / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D053244:Osteoprotegerin; D053245:RANK Ligand; D012333:RNA, Messenger; C506031:Tnfrsf11b protein, mouse; C505689:Tnfsf11 protein, mouse; D016212:Transforming Growth Factor beta; D053509:Matrix Metalloproteinase 13; D020780:Matrix Metalloproteinase 9
references.citation: Surg Oncol Clin N Am. 2001 Apr;10(2):383-92, x
references.pmid: 11382593
references.citation: J Biol Chem. 1994 Jun 17;269(24):16766-73
references.pmid: 8207000
references.citation: Clin Cancer Res. 2004 May 1;10(9):3110-6
references.pmid: 15131051
references.citation: Int J Oncol. 2002 Jul;21(1):25-30
references.pmid: 12063545
references.citation: Cancer Lett. 2009 Apr 18;276(2):212-20
references.pmid: 19114293
references.citation: Crit Rev Biochem Mol Biol. 2002;37(3):149-66
references.pmid: 12139441
references.citation: Mol Cancer Res. 2009 Aug;7(8):1224-33
references.pmid: 19671689
references.citation: Clin Exp Metastasis. 2009;26(7):797-808
references.pmid: 19590968
references.citation: Cancer Cell. 2005 May;7(5):485-96
references.pmid: 15894268
references.citation: Nature. 2006 Apr 27;440(7088):1222-6
references.pmid: 16642001
references.citation: Cancer. 1997 Oct 15;80(8 Suppl):1546-56
references.pmid: 9362421
references.citation: N Engl J Med. 2004 Apr 15;350(16):1655-64
references.pmid: 15084698
references.citation: Cancer Res. 1998 Apr 1;58(7):1348-52
references.pmid: 9537227
references.citation: Br J Cancer. 2003 Apr 22;88(8):1318-26
references.pmid: 12698202
references.citation: Int J Cancer. 2005 Apr 20;114(4):544-54
references.pmid: 15551360
references.citation: Cancer Res. 2008 Jul 15;68(14):5803-11
references.pmid: 18632634
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Adv Immunol. 2000;75:115-57
references.pmid: 10879283
references.citation: Cancer Metastasis Rev. 2006 Dec;25(4):541-9
references.pmid: 17180711
references.citation: Am J Pathol. 1997 Aug;151(2):499-508
references.pmid: 9250162
references.citation: Genes Dev. 2000 Jan 15;14(2):163-76
references.pmid: 10652271
references.citation: J Pathol. 1998 Oct;186(2):144-50
references.pmid: 9924429
references.citation: Cancer Sci. 2009 Jan;100(1):71-81
references.pmid: 19038005
references.citation: Methods Enzymol. 1987;144:140-71
references.pmid: 3041177
references.citation: Cancer Res. 1997 Nov 1;57(21):4882-8
references.pmid: 9354453
references.citation: Nat Clin Pract Oncol. 2006 Jan;3(1):41-9
references.pmid: 16407878
references.citation: Endocr Relat Cancer. 1999 Sep;6(3):333-47
references.pmid: 10516850
references.citation: Cancer Res. 1994 Jun 1;54(11):2823-6
references.pmid: 8187059
references.citation: J Clin Invest. 2009 Apr;119(4):837-51
references.pmid: 19307728
references.citation: Cancer. 1997 Oct 15;80(8 Suppl):1588-94
references.pmid: 9362426
references.citation: Eur J Biochem. 1997 Sep 1;248(2):369-73
references.pmid: 9346290
references.citation: Curr Opin Investig Drugs. 2001 Oct;2(10):1444-9
references.pmid: 11890363
references.citation: Am J Pathol. 1999 Feb;154(2):469-80
references.pmid: 10027405
references.citation: J Bone Miner Res. 1996 May;11(5):665-70
references.pmid: 9157781
references.citation: Clin Exp Metastasis. 2009;26(3):205-13
references.pmid: 19112599
references.citation: Int J Cancer. 1996 Aug 22;69(4):350-3
references.pmid: 8797881
references.citation: Lung Cancer. 2006 Jun;52(3):349-57
references.pmid: 16569461
references.citation: Biochem Biophys Res Commun. 2005 Mar 18;328(3):679-87
references.pmid: 15694401
references.citation: Nat Rev Cancer. 2002 Aug;2(8):584-93
references.pmid: 12154351
references.citation: Clin Cancer Res. 2009 May 1;15(9):3143-9
references.pmid: 19383809
references.citation: J Cell Biol. 2000 Nov 13;151(4):879-89
references.pmid: 11076971
references.citation: J Clin Invest. 1996 Oct 1;98(7):1544-9
references.pmid: 8833902
references.citation: Annu Rev Biochem. 1998;67:753-91
references.pmid: 9759503
references.citation: J Cell Biochem. 1993 Dec;53(4):288-95
references.pmid: 8300745
references.citation: PLoS One. 2009;4(5):e5620
references.pmid: 19440335
references.citation: Cancer Res. 1992 Mar 15;52(6):1399-405
references.pmid: 1540948
references.citation: Cancer Res. 1991 Jun 1;51(11):3059-61
references.pmid: 2032246
references.citation: EMBO J. 1997 Sep 1;16(17):5353-62
references.pmid: 9311995
references.citation: Biochim Biophys Acta. 1999 Dec 10;1489(1):19-30
references.pmid: 10806994
references.citation: Am J Pathol. 1998 Jul;153(1):91-101
references.pmid: 9665469